Thursday 15 October 2026
⬤ News

#startup of the day 20 - Guttify

Reimagining gut health through personalised nutrition

By BioSpectrum Bureau • Published on: 06th October, 2026
#startup of the day 20 - Guttify

Inception - 2023

Location - Gurugram, Haryana, India

Industry domain -  HealthTech / Consumer Health / Gut Health & Diagnostics

Founders - Mukul Shah and Mansi Sharma

Total Team Strength - 50-55

Total funds raised -  Over ₹10.25 crore cumulatively to date, including a ₹4 crore follow-on round in February 2026 .

Investors - Guttify’s investor base includes the family office associated with the Unichem Laboratories family office, Expert Dojo, Agility Ventures, Sunn91 Ventures, government-backed seed programmes, and prominent angel investors including Nitish Mittersain (Nazara Technologies) and Ahana Gautam (Open Secret).


Revenue Generated Since Inception - Business growth metrics: 67% QoQ growth, ~20% monthly user growth and a 40% repeat-user rate.

Current Valuation - Approximately ₹54 crore, based on available reports.

Key Highlights -

  1. Raised a $360,000 extended seed round in May 2025. • Raised a further ₹4 crore follow-on round in February 2026. 
  2. Crossed 30,000 users for its ₹399 DIY Gut Scan Kit.
  3. Recorded 67% quarter-on-quarter growth and approximately 20% monthly user growth. 
  4. Built a 40% repeat-user rate, indicating growing consumer engagement. 
  5. Expanded its positioning from gut-health awareness towards a broader diagnosis-first consumer health platform

Target Fundraise - Having raised over ₹10 crore cumulatively, Guttify is now targeting a ₹20 crore fundraise to strengthen its diagnostic capabilities, expand its product portfolio and deepen its presence across Tier 1 and Tier 2 cities.

Purpose of fundraising - Scaling diagnostic capabilities, technology, product innovation and geographical expansion, particularly across Tier 1 and Tier 2 markets.

Founder Speaks - 

Guttify is planning to raise around ₹20 crore to scale its diagnostic capabilities, strengthen technology and accelerate product innovation. The company plans to expand its presence across Tier 1 and Tier 2 cities and broaden its product portfolio across areas such as bloating, digestion and liver health.

- Mukul Shah 

Published on: 06th October, 2026